On January 13, 2026, the United States Department of Justice (DOJ) announced that Atlantic Biologicals Corporation, a Miami-based pharmaceutical distributor, paid a $450,000 criminal penalty and entered into a two-year deferred prosecution agreement.  The settlement resolves the government’s allegations that from 2017 through May 2023, the company, through its business unit NAS, engaged in…